FDA Warns of Fracture Risk with Diabetes Drug Canagliflozin (FREE)
By Kelly Young
Edited by André Sofair, MD, MPH, and William E. Chavey, MD, MS
The type 2 diabetes drug canagliflozin will carry a stronger label warning about the increased risk …
Source: Physician's First Watch current issue - Category: Primary Care Source Type: news
More News: Canagliflozin | Diabetes | Diabetes Type 2 | Endocrinology | Invokana | Primary Care | Warnings